TKPHF — TAKEDA PHARMACEUTICAL CO LTD
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 1395064 ·
Last close
$35.89
Market Cap
$57.31B
52W High
$35.89
52W Low
$29.33
ADV30
17,453
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 1,219,900,000,000 | 813,224,000,000 | 201,417,000,000 | 113,197,000,000 | 15,663,271,000,000 | 460,982,000,000 | 8,104,395,000,000 |
| Mar 2026 | 1,094,541,000,000 | 688,837,000,000 | 42,068,000,000 | -368,471,000,000 | 15,511,506,000,000 | 595,054,000,000 | 8,080,857,000,000 |
| Dec 2025 | 1,191,698,000,000 | 790,550,000,000 | 168,822,000,000 | 103,640,000,000 | 15,408,774,000,000 | 654,937,000,000 | 7,764,684,000,000 |
| Sep 2025 | 1,112,796,000,000 | 732,735,000,000 | 68,996,000,000 | -11,802,000,000 | 14,470,300,000,000 | 681,486,000,000 | 7,338,611,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$1,189,062,000,000
Investing CF
$-330,806,000,000
Financing CF
$-721,117,000,000
CapEx
$-442,990,000,000
Dividends Paid
$-312,852,000,000
Buybacks
$-101,581,000,000
EPS Diluted TTM
$78.23
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$1,095,662,000,000
Inventory
$1,407,192,000,000
Receivables
$757,921,000,000
ST Investments
$107,004,000,000
EBIT TTM
$496,862,000,000
Pretax Income TTM
$205,369,000,000
Interest Exp TTM
$291,493,000,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$4,618,934,812,672
EBITDA
$1,249,335,967,744
Free Cash Flow
$541,443,883,008
Enterprise Value
$5,133,223,067,648
Total Cash
$460,981,993,472
Total Debt
$5,536,499,105,792
Shares Out
1,596,751,439
Trailing EPS
$-0.64
Book Value
$28.80
ROE
-2.3%
ROA
2.7%
Div Yield
3.61%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 4,505,720,000,000 | 464,451,000,000 | -152,390,000,000 | 15,511,506,000,000 | 8,080,857,000,000 | — | 1,041,431,000,000 |
| Mar 2025 | 4,581,551,000,000 | 466,370,000,000 | 107,928,000,000 | 14,248,344,000,000 | 7,312,365,000,000 | — | 1,057,182,000,000 |
| Mar 2024 | 4,263,762,000,000 | 309,901,000,000 | 144,067,000,000 | 15,108,792,000,000 | 7,834,787,000,000 | — | 716,344,000,000 |
| Mar 2023 | 4,027,478,000,000 | 587,812,000,000 | 317,017,000,000 | 13,957,750,000,000 | 7,603,079,000,000 | — | 977,156,000,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.81
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TAK | TAKEDA PHARMACEUTICAL CO LTD | $54.58B | $17.09 | — |
| REGN | REGENERON PHARMACEUTICALS, INC. | $77.13B | $762.63 | — |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | $40.80B | $35.01 | — |
| TEVJF | TEVA PHARMACEUTICAL INDUSTRIES LTD | $33.09B | $28.40 | — |
| GLAXF | GSK plc | $99.94B | $24.95 | — |
News headlines (Yahoo Finance, 1h cache)
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate
2026-07-31 06:30 · Yahoo
Keros Therapeutics to Receive Development Milestone Payment from Partner Takeda
2026-07-30 20:01 · Yahoo
Takeda Pharmaceutical Q1 Earnings Call Highlights
2026-07-30 12:03 · Yahoo
Takeda Announces FY2026 First Quarter Results, Near-Term Launch Preparations and Pipeline Progress on Track
2026-07-30 06:37 · Yahoo
How New Phase 3 Psoriasis Data For Zasocitinib At Takeda Pharmaceutical (TSE:4502) Has Changed Its Investment Story
2026-07-27 03:16 · Yahoo
Takeda (TSE:4502) Stock Looks Below Fair Value While Broader Checks Stay Mixed
2026-07-26 23:12 · Yahoo
Takeda Pharmaceutical (TSE:4502) Reports New Phase 3 Psoriasis Data, Is The 10% Discount Enough?
2026-07-26 09:09 · Yahoo
Takeda (TSE:4502) Expands In Indonesia As Psoriasis Drug Delivers Phase 3 Data
2026-07-26 04:17 · Yahoo
Asian Equities Traded in the US as American Depositary Receipts Decline in Friday Trading
2026-07-24 14:40 · Yahoo
Change in Siegfried's Management Team
2026-07-16 22:32 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.